Physician profile
Stacey A Stinger
NPI 1619374451
$5,956.94
in general payments reported to CMS, 2019-2025
35 companies · $1,660 in 2025
The $1,660 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $895 · 2022: $1,099 · 2023: $1,389 · 2024: $914 · 2025: $1,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,962.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $771.43 | 2021-2025 | |
| Abbvie INC. | $744.67 | 2021-2025 | |
| Novo Nordisk INC | $738.99 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $681.07 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $492.71 | 2021-2025 | Evenity, Otezla, Repatha |
| Lilly USA, LLC | $294.34 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $236.28 | 2022-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $227.15 | 2021-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.81 | 2021-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $149.05 | 2021-2023 | |
| Radius Health, INC. | $128.86 | 2023-2025 | Tymlos |
| Esperion Therapeutics, INC. | $126.82 | 2023-2025 | Nexletol |
| Exact Sciences Corporation | $118.95 | 2024-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $111.81 | 2021-2023 | Glassia |
| Merck Sharp & Dohme LLC | $101.75 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Stinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.